| Using best–worst scaling to investigate preferences in health care KL Cheung, BFM Wijnen, IL Hollin, EM Janssen, JF Bridges, SMAA Evers, ... Pharmacoeconomics 34, 1195-1209, 2016 | 217 | 2016 |
| Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness EM Janssen, EE McGinty, ST Azrin, D Juliano-Bult, GL Daumit General hospital psychiatry 37 (3), 199-222, 2015 | 161 | 2015 |
| Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability? EM Janssen, DA Marshall, AB Hauber, JFP Bridges Expert review of pharmacoeconomics & outcomes research 17 (6), 531-542, 2017 | 120 | 2017 |
| Assessing rationality in discrete choice experiments in health: an investigation into the use of dominance tests T Tervonen, T Schmidt-Ott, K Marsh, JFP Bridges, M Quaife, E Janssen Value in Health 21 (10), 1192-1197, 2018 | 71 | 2018 |
| A framework for instrument development of a choice experiment: an application to type 2 diabetes EM Janssen, JB Segal, JFP Bridges The Patient-Patient-Centered Outcomes Research 9, 465-479, 2016 | 71 | 2016 |
| Conducting a discrete-choice experiment study following recommendations for good research practices: an application for eliciting patient preferences for diabetes treatments EM Janssen, AB Hauber, JFP Bridges Value in Health 21 (1), 59-68, 2018 | 57 | 2018 |
| Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects EM Janssen, SM Dy, AS Meara, PJ Kneuertz, CJ Presley, JFP Bridges Patient preference and adherence, 927-937, 2020 | 51 | 2020 |
| Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey J Mendivil, R Murphy, M de la Cruz, E Janssen, HB Boysen, G Jain, ... Orphanet journal of rare diseases 16, 1-13, 2021 | 37 | 2021 |
| Preferred clinician communication about stopping cancer screening among older US adults: results from a national survey NL Schoenborn, EM Janssen, CM Boyd, JFP Bridges, AC Wolff, ... JAMA oncology 4 (8), 1126-1128, 2018 | 36 | 2018 |
| Older adults’ preferences for discussing long-term life expectancy: results from a national survey NL Schoenborn, EM Janssen, C Boyd, JFP Bridges, AC Wolff, QL Xue, ... The Annals of Family Medicine 16 (6), 530-537, 2018 | 35 | 2018 |
| Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment EM Janssen, DR Longo, JK Bardsley, JFP Bridges Patient preference and adherence, 1729-1736, 2017 | 30 | 2017 |
| The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management Y Jackson, E Janssen, R Fischer, K Beaverson, J Loftus, K Betteridge, ... Expert Review of Pharmacoeconomics & Outcomes Research 19 (4), 383-396, 2019 | 28 | 2019 |
| Caregiver treatment preferences for children with a new versus existing attention-deficit/hyperactivity disorder diagnosis S DosReis, A Park, X Ng, E Frosch, G Reeves, C Cunningham, ... Journal of child and adolescent psychopharmacology 27 (3), 234-242, 2017 | 25 | 2017 |
| Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults NL Schoenborn, QL Xue, CE Pollack, EM Janssen, JFP Bridges, AC Wolff, ... Preventive medicine reports 13, 244-248, 2019 | 22 | 2019 |
| Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy IL Hollin, H Peay, R Fischer, EM Janssen, JFP Bridges Quality of Life Research 27, 2261-2273, 2018 | 21 | 2018 |
| Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach EM Janssen, HL Benz, JH Tsai, JFP Bridges Expert review of medical devices 15 (5), 385-398, 2018 | 21 | 2018 |
| AcroVoice: eliciting the patients’ perspective on acromegaly disease activity Y Jackson, E Flood, S Rhoten, EM Janssen, M Lundie Pituitary 22, 62-69, 2019 | 19 | 2019 |
| A roadmap for increasing the usefulness and impact of patient-preference studies in decision making in health: a good practices report of an ISPOR task force JFP Bridges, EW de Bekker-Grob, B Hauber, S Heidenreich, E Janssen, ... Value in Health 26 (2), 153-162, 2023 | 18 | 2023 |
| Exploring variation in parental worries about HPV vaccination: a latent-class analysis MB Gilkey, D Mohan, EM Janssen, AL McRee, ML Kornides, JFP Bridges Human Vaccines & Immunotherapeutics, 2019 | 16 | 2019 |
| Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer JFP Bridges, M la Cruz, M Pavilack, E Flood, EM Janssen, N Chehab, ... Future Oncology 15 (34), 3895-3907, 2019 | 14 | 2019 |
Craig PollackJohns Hopkins School of MedicineEmail verificata su jhmi.edu
